INFUSYSTEM HOLDINGS, INC Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INFUSYSTEM HOLDINGS, INC shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-06-30 was $5.00K.
- INFUSYSTEM HOLDINGS, INC shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-03-31 was $31.00K.
- INFUSYSTEM HOLDINGS, INC shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-09-30 was $55.00K.
- INFUSYSTEM HOLDINGS, INC shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2025 was $55.00K, a 22.22% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2024 was $45.00K, a 92.72% decline from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2023 was $618.00K, a 30.64% decline from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2022 was $891.00K, a 9.73% increase from fiscal 2021.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | $5.00K 10-Q · filed 2026-08-04 | $91.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $31.00K 10-Q · filed 2026-05-08 | $86.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $55.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $55.00K 10-Q · filed 2025-11-04 | $61.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-04 | $6.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | $45.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $45.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-04 | $71.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $39.00K 10-Q · filed 2025-08-05 | $71.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $303.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $618.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | $792.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-06-30 | $271.00K 10-Q · filed 2024-08-09 | $1.00M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $315.00K 10-Q · filed 2024-05-09 | $967.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $891.00K 10-K · filed 2024-04-10 |
| 2022-09-30 | $212.00K 10-Q · filed 2023-11-09 | $1.07M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-06-30 | $234.00K 10-Q · filed 2023-08-09 | $892.00K derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-03-31 | $239.00K 10-Q · filed 2023-05-09 | $912.00K derived: sum of 4 quarters · filed 2024-04-10 |
| 2021-12-31 | $381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $812.00K 10-K · filed 2024-04-10 |
| 2021-09-30 | $38.00K 10-Q · filed 2022-11-08 | $431.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $254.00K 10-Q · filed 2022-08-04 | $393.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $139.00K 10-Q · filed 2022-05-05 | $139.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $15.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $124.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $139.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $139.00K 10-K · filed 2022-03-15 |
| 2019-09-30 | $109.00K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $15.00K 10-Q · filed 2020-08-14 | |
| 2016-12-31 | $0.00 10-K · filed 2017-03-22 | |
| 2015-12-31 | $0.00 10-K/A · filed 2016-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |